ADAG Earnings Date: Mar 31, 2027 (Estimated) — Adagene Inc. American Depositary Shares
XNAS
Updated
When is ADAG's next earnings date?
Adagene Inc. American Depositary Shares (ADAG) is expected to report FY 2026 earnings on Wednesday, March 31, 2027 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.52 on revenue of $1.9M.
How did ADAG do in its last earnings report?
In its most recent report on Aug 12, 2026 (H1 2026), Adagene Inc. American Depositary Shares posted EPS of -$0.20 versus the -$0.22 estimate, a beat of 42.9%. Revenue was $1.6M against a $17.5M estimate. The stock's 1-day post-earnings move was -3.6%.
How much does ADAG stock move after earnings?
ADAG beat EPS estimates in 2 of its last 4 reported quarters. Over the last 8 reports the stock moved an average of 8.9% (up or down) in the day after earnings.
About Adagene Inc. American Depositary Shares
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | H1 2026 | -0.22 | -0.20 | -42.86% | $1.6M | ✅ Beat | -3.60% | +4.11% | -14.91% |
| 2026-04-01 | FY 2025 | -0.61 | -0.24 | +60.66% | $7.7M | ✅ Beat | -13.45% | -16.59% | -17.14% |
| 2025-08-12 | H1 2025 | -0.11 | -0.19 | -72.73% | $0 | ❌ Miss | -13.61% | +2.62% | +22.51% |
| 2025-03-24 | FY 2024 | — | -0.64 | — | $103,204 | — | +5.04% | -7.72% | -13.95% |
| 2024-07-25 | H1 2024 | — | -0.26 | — | $0 | — | -0.40% | +2.37% | +16.60% |
| 2024-03-29 | FY 2023 | — | -0.26 | — | $18.1M | — | +15.71% | +1.79% | -19.64% |
| 2023-08-31 | H1 2023 | — | 0.00 | — | $17.3M | — | +15.25% | +18.64% | +29.66% |
| 2023-03-28 | FY 2022 | -1.58 | -1.60 | -1.27% | $9.3M | ❌ Miss | +4.14% | -5.52% | -11.03% |
Showing last 8 quarters.